Published in Blood on December 01, 1987
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Cefoperazone prevents the inactivation of alpha(1)-antitrypsin by activated neutrophils. Antimicrob Agents Chemother (1999) 0.78
Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1994) 0.76
Proteasome inhibitors: antitumor effects and beyond. Leukemia (2006) 1.87
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood (2001) 1.24
Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature (1989) 1.13
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J Natl Cancer Inst (1984) 1.07
Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation. Int J Tissue React (1990) 1.07
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. Acta Haematol (1993) 1.05
Mechanisms of tumour cell destruction by PMA-activated human neutrophils. Immunology (1983) 0.97
Inhibition of neutrophil cytolysin production by target cells. Blood (1986) 0.96
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol (2000) 0.93
Defective antibody-dependent tumour cell lysis by neutrophils from cancer patients. Clin Exp Immunol (1989) 0.92
Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils. Clin Exp Immunol (1987) 0.91
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. Br J Cancer (2006) 0.91
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Haematologica (2000) 0.91
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. Curr Cancer Drug Targets (2012) 0.89
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation (1991) 0.88
Immune complex stimulation of neutrophil apoptosis: investigating the involvement of oxidative and nonoxidative pathways. Free Radic Biol Med (2001) 0.87
Neutrophil-induced depletion of adenosine triphosphate in target cells: evidence for a hypochlorous acid-mediated process. J Lab Clin Med (1988) 0.87
Effects of ascorbic acid on neutrophil locomotion. Int Arch Allergy Appl Immunol (1980) 0.85
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. Curr Cancer Drug Targets (2012) 0.85
Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates. Immunology (1987) 0.85
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. Cancer (2001) 0.84
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. Scand J Immunol (1983) 0.84
Down-regulation of K cell activity by neutrophils. Blood (1985) 0.84
Erythrocyte lysis by PMA-triggered neutrophil polymorphonuclears: evidence for an hypochlorous acid-dependent process. Immunology (1985) 0.84
Neutrophil-mediated cellular cytotoxicity triggered by immobilized aggregated IgG: an in vitro model of cell injury during immune complex diseases. J Clin Immunol (1984) 0.84
Serum-associated inhibition of neutrophil Fc receptors in cancer patients. J Natl Cancer Inst (1981) 0.84
Evidence for a reversible functional state of neutrophil chemotactic deactivation. Int Arch Allergy Appl Immunol (1980) 0.84
Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears. Exp Hematol (1982) 0.83
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. Haematologica (1997) 0.83
Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid. Br J Dermatol (1980) 0.83
Molecular characterization of an Italian series of sporadic GISTs. Gastric Cancer (2013) 0.83
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. Curr Cancer Drug Targets (2012) 0.83
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. Int J Lab Hematol (2009) 0.83
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer. J Clin Oncol (1995) 0.83
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. J BUON (2011) 0.82
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. Curr Cancer Drug Targets (2012) 0.82
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. Curr Cancer Drug Targets (2012) 0.82
Stimulation of neutrophil chemotaxis, adhesiveness, phagocytosis, and hexose monophosphate shunt activity by N-(2-mercaptopropionyl)glycine. Res Exp Med (Berl) (1981) 0.82
Neutrophil functions in acne conglobata. Dermatologica (1979) 0.82
In vitro effects of synthetic chemotactic peptides on neutrophil function. Int Arch Allergy Appl Immunol (1980) 0.82
Neutropenia and impaired neutrophil function in glycogenosis type Ib. J Inherit Metab Dis (1984) 0.81
Ultrasonography-guided endoscopic stent placement for malignant biliary obstruction: a preliminary report of four cases. Endoscopy (2004) 0.81
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry. Bone Marrow Transplant (2012) 0.80
Anticancer vaccination strategies. Ann Oncol (2004) 0.80
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. Exp Hematol (1983) 0.80
Reversal by cimetidine of histamine-induced inhibition of true chemotaxis in neutrophil polymorphonuclears. Res Exp Med (Berl) (1980) 0.80
Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease. Acta Hepatogastroenterol (Stuttg) (1978) 0.80
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. Curr Cancer Drug Targets (2010) 0.80
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. Cancer Immunol Immunother (1999) 0.80
Extracellular cytotoxicity by phagocytosing polymorphonuclear neutrophilic leukocytes: enhancement by a chemotactic stimulus. Exp Hematol (1985) 0.79
Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically. J Med Virol (2000) 0.79
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma. Int J Oncol (2000) 0.79
Erythrocyte lysis by monocytes: investigations on the mechanism and role of the target cell hydrogen peroxide catabolizing pathways. J Clin Lab Immunol (1987) 0.79
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. Br J Cancer (1997) 0.78
Modulation of neutrophil Fc and C3b receptors. Relationship with the phagocytic process and activation of the respiratory burst. Inflammation (1983) 0.78
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. Leuk Res (1995) 0.78
Platelets as inhibitory cells in neutrophil-mediated cytolysis. J Lab Clin Med (1989) 0.78
[Ultrasound-guided endoscopic drainage, without radiological examination, in patients with neoplastic biliary obstruction. Preliminary results]. Minerva Chir (2004) 0.77
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer (2005) 0.77
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. Res Exp Med (Berl) (1980) 0.77
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. Thromb Haemost (1989) 0.77